Celegence, a provider of regulatory affairs services, completed the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for pharmaceutical products. Financial terms were not disclosed. "Qdossier's regulatory expertise and technology complements our own portfolio of services and solutions. We work with our clients as trusted advisors with the aim of improving efficiency in regulatory compliance, helping them to successfully launch new products to market and maintain them. The combination of Celegence and Qdossier's expertise, coupled with technology that supports compliance and effective data and document management, will enable us to deliver hands-on, strategic, highly personalized regulatory support to pharmaceutical industries across the globe," Sonia Veluchamy, Celegence CEO.